Vectorious Medical Technologies today announced interim results from a pilot study of its V-LAP sensor for heart failure management. Tel Aviv, Israel-based Vectorious presented results from the left atrial pressure (LAP) guided patient self-management study at during an abstract session at THT 2023 in Boston. The study has 13 enrolled patients to date. It includes […]
THT 2023
Data backs splanchnic ablation procedure from Axon Therapies
Axon Therapies today announced positive six-month results from a trial for its proprietary splanchnic ablation for volume management (SAVM) therapy. Dr. Marat Fudim, advanced heart failure specialist at Duke University Medical Center, presented results at the Technology and Heart Failure Therapeutics (THT) Conference in Boston. The data came from a roll-in cohort for the REBALANCE-HF […]
AccuCinch ventricular restoration system from Ancora Heart improves heart failure outcomes
Ancora Heart announced today that its AccuCinch system demonstrated improvement in heart failure patient outcomes in an analysis. Patients treated with the investigational device also saw beneficial changes in the structure of the heart. Twelve-month data were presented at the Technology and Heart Failure Therapeutics conference (THT 2023) and simultaneously published in the Journal of Cardiac […]
Study says heart failure survival improves with Abbott CardioMEMS monitoring tech
Hemodynamic pressure sensing with Abbott’s CardioMEMS HF system can significantly reduce the risk of death from heart failure. That’s according to a meta-analysis of three randomized, controlled trials that Abbott presented today at the Technology and Heart Failure Therapeutics (THT) Conference in Boston. The data comes from an analysis evaluating CardioMEMS HF in heart failure […]
Aortix circulatory support device from Procyrion produces positive study results
Procyrion today announced study results demonstrating that use of its Aortix device led to rapid decongestion in a pilot study. Houston-based Procyrion evaluated Aortix percutaneous mechanical circulatory support (pMCS) pump in patients with acute decompensated heart failure (ADHF) and worsening renal function. This is known as cardiorenal syndrome (CRS). The pump patients — unresponsive to […]
Study backs CVRx Barostim neuromod for patients with heart failure
Data presented today supported the use of the Barostim neuromodulation device from CVRx (Nasdaq:CVRX) in patients with cardiovascular diseases. The BeAT-HF trial evaluated the Barostim extravascular, implantable neuromodulation device. Dr. Michael Zile, professor of cardiology at the Medical University of South Carolina, presented findings at the second annual Technology and Heart Failure (HF) Therapeutics (THT) […]
